PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Excessive release of neutrophil extracellular traps (NETs) has been implicated in several organ fibrosis, including pulmonary fibrosis. NETs constitute a phenomenon in which decorated nuclear chromatin with cytosolic proteins is released into the extracellular space. PAD4 (peptidylarginine deiminase 4) plays an important role in the formation of NETs. However, the role of NETs in the pathogenesis of pulmonary fibrosis remains undefined. Here, we identified NETs in the alveolar and interstitial lung space of mice undergoing bleomycin (BLM)-induced lung fibrosis, which was suppressed by a pan-PAD inhibitor, Cl-amidine. In vitro, BLM directly induced NETs in blood neutrophils, which was also inhibited by Cl-amidine. Furthermore, Padi4 gene knockout (PAD4-KO) in mice led to the alleviation of BLM-induced NETs and pulmonary fibrosis and to the expression of inflammatory and fibrotic genes. PAD4 deficiency prevented decreases in alveolar epithelial and pulmonary vascular endothelial cell numbers and increases in ACTA2-positive mesenchymal cells and S100A4-positive fibroblasts in the lung. Hematopoietic cell grafts from PAD4-KO mice, not wild-type mice, resolved BLM-induced lung fibrosis and fibrotic gene expression in wild-type and PAD4-KO mice, suggesting that expression of PAD4 in hematopoietic cells may be involved in the development of lung fibrosis. These data suggest that PAD4 deficiency could ameliorate BLM-induced formation of NETs and lung fibrosis, suggesting that this pathway could serve as a therapeutic target for pulmonary fibrosis treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stiff substrates promote increased neutrophil spreading, ROS production, and the release of neutrophil extracellular traps (NETs), a process termed NETosis (95,96).”
From The mechanotransduction-immune axis in organ fibrosis: dual regulatory mechanisms and translational therapeutic perspectives (2025) · doi:10.3389/fimmu.2025.1670213 · cites this paper as [100]
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Novel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Papayannopoulos, V., Metzler, K. D., Hakkim, A., & Zychlinsky, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006052 · Cited by 2,103
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Saffarzadeh, M., Juenemann, C., Queisser, M. A., Lochnit, G., Barreto, G., Galuska, S. P., Lohmeyer, J., & Preissner, K. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032366 · Cited by 1,335
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Warnatsch, A., Ioannou, M., Wang, Q., & Papayannopoulos, V. (2015) · Science · doi:10.1126/science.aaa8064 · Cited by 1,270
Cited by
Items 101–143 of 143
Du, Y., Zhu, C., Wang, R., Chen, S., Li, C., Ouyang, D., Liu, L., & Chen, Y. (2025) · Advanced Science · doi:10.1002/advs.202505357 · Cited by 4
Li, X., Ju, Y., Xu, C., Ma, S., Lan, S., Guo, Q., Liu, M., Xie, Y., & Min, L. (2025) · Advanced Science · doi:10.1002/advs.202507867 · Cited by 4
TNFAIP3, PADI4, and CXCR4 as biomarkers of neutrophil extracellular traps in severe asthma
Han, Y., Ji, X., Rao, J., Zhang, Y., Chen, X., & Gong, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116118 · Cited by 5
Neutrophil extracellular traps in pulmonary fibrosis: mechanisms, immunity and therapeutic targets
Wu, J., & Hu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1765590 · Cited by 4
Yang, C., Wang, G., Zhan, W., Wang, Y., & Feng, J. H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1173961 · Cited by 4
Resolution of innate immune cells with proresolving lipid mediators in idiopathic pulmonary fibrosis
Ang, Y., Ng, A. J. K., Liao, W., Wong, K. Y. K., Wong, W. S. F., & Peh, H. Y. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf100 · Cited by 3
Asaba, C. N., Gwanyama, B. N., Ayuk, H. S., Odo, T. I., Bitazar, R., Noumi, T., Labonté, P., & Bukong, T. N. (2026) · Cells · doi:10.3390/cells15070580 · Cited by 4
Zeng, X., Li, J., Pei, L., Yang, Y., Chen, Y., Wang, X., Zhang, T., & Zhou, T. (2024) · Pulmonary Circulation · doi:10.1002/pul2.12454 · Cited by 3
Myeloid‐Mesenchymal Crosstalk in Lung Fibrosis
Bhattacharyya, A., Yadav, P., & Bhattacharya, M. (2025) · Comprehensive physiology · doi:10.1002/cph4.70004 · Cited by 3
“Once recruited to the fibrotic niche, neutrophils release various factors to promote fibrosis, including neutrophil elastase (NE), which has been reported to cause myofibroblast transformation and to increase TGF-β expression (Suzuki et al. 2020).”
Li, Z., Wang, S., Bai, Y., Liu, S., Huang, J., You, Y., Li, J., Yu, X., Han, Y., & Bao, X. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.07.023 · Cited by 3
Aoyama-Ishikawa, M., Higashi, H., Murakami, H., Inoue, T., Fujisaki, N., & Kohama, K. (2025) · Surgical Infections · doi:10.1177/10962964251376946 · Cited by 2
Hong, S.-H., Yun, B., Cho, S., Hong, O., LEE, S. H., Kim, W.-H., & Hong, J.-Y. (2026) · Clinical Science · doi:10.1042/cs20258382 · Cited by 3
Catalpol mitigates rheumatoid arthritis by targeting neutrophil extracellular trap release
Li, C., Wang, L., Li, Q., Zhao, W., Hui, Z., Zhang, Z., & Zhao, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1763586 · Cited by 2
Ye, S., Dong, Z., Jiang, X., Li, X., Wang, X., Li, B., Yu, R., Fan, G., Wang, Y., Zhu, M., et al. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s603127 · Cited by 2
“[61] ( Continued )”
Sanchez, N. C., Gopikrishnan, M., Nowak, J. I., Jones, C., Kim, Y.-I., Sharma, N., Zmijewski, J. W., & Surolia, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-95645-z · Cited by 1
“NETs promote pro-fibrotic signaling, and the transgenic mice model of NETs deficiency are protected from bleomycin-induced lung fibrosis 34 .”
Sadek, M. A., ElBishbishy, R. M., Lotfy, R. M., Fayez, N., Sayed, G. A., El‐Shiekh, R. A., & Hal, D. M. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500981 · Cited by 3
The role of immune cell crosstalk and signaling pathways in the pathogenesis of pulmonary fibrosis
Liu, X., Chen, H., Guo, C., Lin, Y., Wang, F., & Lan, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11437-2 · Cited by 5
“…excessive NET formation may theo - retically cause epithelial damage through cytotoxicity medi - ated by histones and proteases, more validation in patient samples and experimental models is still needed to deter - mine their causative role in fibrotic remodeling and alveo - lar damage [ 41 , 42].”
Monocyte-mediated mechanisms in idiopathic pulmonary fibrosis: opportunities for early intervention
Zhiguo, M. A. O., Liu, Y., Han, C., Yang, X., Lin, X., Tian, S., & Miao, M. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02254-2 · Cited by 2
“Research has demonstrated a correlation between elevated neutrophil percentages in BALF and both the severity of IPF and increased mortality rates [34, 36 ].”
Endothelial Hippo pathway regulates the neutrophil niche and lung fibrosis
Wu, C., Chen, X., Zhou, J., Wang, H., Huang, X., Tang, X., Cao, Z., & Ding, B. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108169 · Cited by 1
He, X., Yuan, X., Sa, X., Ban, J., Fu, S., You, M., & Li, J. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04415-0 · Cited by 1
“They are associated with various pathophysiological conditions, including autoimmune diseases, chronic inflammatory diseases, cancer, and tissue repair, through mechanisms such as degranulation, phagocytosis, and the release of neutrophil extracellular traps (NETs) [13, 14].”
Zhou, W., Wang, Z., Du, H., Zhao, W., Zhang, T., Liu, Z. H., Qu, J., & Sun, Y. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158386 · Cited by 1
Dragoni, G., Ke, B.-J., Verstockt, B., Abdurahiman, S., Innocenti, T., Hertogh, G. D., Galli, A., Matteoli, G., & Vermeire, S. (2022) · Gastroenterology · doi:10.1016/s0016-5085(22)60260-9
Li, W., Xue, L., Zeng, Q., Hao, X., Liu, L., Liang, C., Zhou, W., Liu, Y., Deng, G., Xiong, W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4657470/v1
Wang, Z., Wang, P., He, G., Cheng, L., Li, T., Wang, Y., & Li, H. (2025) · Current Gene Therapy · doi:10.2174/0115665232257596231011110813
Tirzepatide reduces diet-induced senescence and NETosis-mediated liver fibrosis in micePreprint
Chen, F., Nam, Q., Wang, L. D., Chammas, F., Wüestefeld, T., Lee, B. T. K., & Wong, S. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656284 · Cited by 1
Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links
Rodríguez-Herrera, A. J., Batah, S. S., Marco, M. J. F. D., González-Zambrano, C. M., Dias‐Melicio, L. A., & Fabro, A. T. (2025) · Infectious Disease Reports · doi:10.3390/idr17040084
Kooistra, E. J., Dahm, K., van Herwaarden, A. E., Gerretsen, J., Nuesch-Germano, M., Mauer, K., Smeets, R. L., van der Velde, S., van den Berg, M. J. W., van der Hoeven, J. G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23916723
Hu, X., Qian, X., & Wen, J. (2026) · Inhalation Toxicology · doi:10.1080/08958378.2025.2609729
“Pharmacologic disruption of PAD4-driven chromatin de-condensation attenuates NET burden and downstream fibrotic signaling in lung injury models, highlighting a plausible intervention point for chronic exposure settings (Suzuki et al. 2020).”
Jin, F., Li, Y., Li, T., Liu, S., Xu, D., Liu, H., Wei, Z., Gao, X., Mao, N., Cai, W., et al. (2026) · Particle and Fibre Toxicology · doi:10.1186/s12989-026-00671-y
“Padi4 knockout models have shown attenuation of bleomycin (BLM)-induced neutrophil extracellular traps (NETs), fibrotic gene expression, and lung fibrosis in mice [7].”
Rashad, A. M., El-Khazragy, N. N., Awad, H. A., Gad, G. I., & Rabie, D. E. A. (2026) · Pediatric Research · doi:10.1038/s41390-026-04824-9
Neutrophil extracellular Trap-related genes in NAFLD: Biomarkers and therapeutic targets
Rao, H., Chen, J., Chen, Y., & Jiang, J. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02139-x
Myeloperoxidase promotes fibrosis by inhibiting cathepsin K to bias the lung toward ECM accumulationPreprint
Link, P. A., Wellmerling, J. H., Meridew, J. A., Naoi, H., Prakash, Y. S., Rojas, M. M., Carmona, E. M., & Tschumperlin, D. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.05.713467
Chen, Y.-H., Ke, Z., Lin, B.-H., Xu, Y., Xue, X.-Y., Zheng, Q., Sun, X., Yong, W., LIANG, Y.-C., & Xu, N. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02368-1 · Cited by 1
“It was reported that NETs are key pathogenic factors in pulmonary fibrosis, while bleomycin-induced fibrosis would be alleviated in pep - tidylarginine deiminase 4 (PAD4)-knockout murine models [ 17 ].”
Repeated air pollution exposure predisposes to adverse outcomes from acute lung injury
Monge, C., Majumder, N., Cumming, R. I., Mazumder, H. H., Li, Y., Goldsmith, W. T., Mahavithana, P., Ranpara, A. C., Tighe, R. M., Harkema, J. R., et al. (2026) · Particle and Fibre Toxicology · doi:10.1186/s12989-026-00686-5
Yang, J., Liu, Y., Meng, Y., Wang, H., Zhou, X., Zhao, X. Y., & Feng, C. J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1778590
“…damage pulmonary epithelial and vascular endothelial cells, exacerbate local inflammatory responses (Keir and Chalmers, 2022) and tissue fibrosis (Suzuki et al., 2020), but also disrupt the body’s immune homeostasis, thereby further amplifying the persistent lung injury caused by FPM…”
Chen, D., & Xiang, F. (2026) · Canadian Respiratory Journal · doi:10.1155/carj/6653364
“PAD4 defciency attenuates NET formation, prevents the reduction of vascular endothelial and epithelial cells, and inhibits the accumulation of ACTA2-positive mesenchymal stromal cells, thereby ameliorating bleomycin-induced PF [76].”
Zeng, L., Xue, B., Ren, X., 宫树桐, & Yan, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1781229
Angiogenesis in Lung Regeneration and Aging
Kyi, P., Scheer, M., Mammoto, T., & Mammoto, A. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324410
Lang, C., Wu, J., & Wang, N. (2026) · Molecular Genetics and Genomics · doi:10.1007/s00438-026-02473-5
“In post-COVID-19 fibrosis, NETs can trigger EMT, a transformation where epithelial cells acquire mesenchymal attributes, contributing to fibrosis and tissue remodeling (Suzuki et al. 2020 ; Wang et al. 2024 ).”
Neutrophil extracellular traps (NETs) and pulmonary fibrosis: Mechanisms and implications
Chen, Z., Tang, J., Wang, Z., Gu, Z., Liu, J., Zhu, L., Cheng, X., Liu, Y., Zhao, X., & Cheng, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117391 · Cited by 1
Bi, W., Zhou, Y., Gong, J., 劉玟儀, Li, J., Du, J., Nie, H., Luo, H., Zhang, H., Cai, Q., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.10.008
You, Y., Wang, P., Huang, J., Zhang, X., Han, F., Liu, J., Xu, D., Liu, Y., Bao, X., & Zhu, X. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112373
Metadata
- Authors
- Suzuki, M., Ikari, J., Anazawa, R., Tanaka, N., Katsumata, Y., Shimada, A., Suzuki, E., & Tatsumi, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Ikari, Jun
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 63
- Issue
- 6
- Pages
- 806-818
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W3085038700
- Cited by
- 143
- References
- 50
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 28 · 2023: 21 · 2022: 20 · 2021: 11
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- PAD4, neutrophil extracellular traps, pulmonary fibrosis, bleomycin-induced lung injury, Cl-amidine, hematopoietic cells, alveolar epithelial cells, pulmonary endothelial cells, fibroblasts, mesenchymal cells, S100A4, ACTA2, therapeutic target
- MeSH terms
- Protein-Arginine Deiminase Type 4, Animals, Bleomycin, Disease Models, Animal, Fibrosis, Lung, Male, Mice, Inbred C57BL, Neutrophils, Pulmonary Fibrosis, Mice, Knockout, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.